TSC1 Mutations Confer Sensitivity to Everolimus

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2012-144
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Next-Generation Sequencing Reveals Somatic Mutations That Confer Exceptional Response to Everolimus

Oncotarget
Oncology
2016English

Germline Mutations in TMEM127 Confer Susceptibility to Pheochromocytoma

Nature Genetics
Genetics
2010English

Mutations for Gaucher Disease Confer High Susceptibility to Parkinson Disease

Archives of Neurology
2009English

MEK1 Mutations Confer Resistance to MEK and B-Raf Inhibition

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

FLT3 D835 Mutations Confer Differential Resistance to Type II FLT3 Inhibitors

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2015English

SWI/SNF Mutations Confer Resistance to Ibrutinib Plus Venetoclax in MCL

Cancer Discovery
Oncology
2018English

Disparate Mutations Confer Therapeutic Gain of Hsp104 Function

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2015English

Resistance to the Cyclotide Cycloviolacin O2 in Salmonella Enterica Caused by Different Mutations That Often Confer Cross-Resistance or Collateral Sensitivity to Other Antimicrobial Peptides

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Kinase Domain Mutations Confer Resistance to Novel Inhibitors Targeting JAK2V617F in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy